FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Sarris

Research Profile

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Marco Herling; George Z Rassidakis; Theodoros P Vassilakopoulos; L Jeffrey Medeiros; Andreas H Sarris
Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma.
Deborah A Thomas; Andreas H Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien; Francis Giles; Guillermo Garcia-Manero; Maria A Rodriguez; Fernando Cabanillas; Andrew Lamb
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Sarris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
European journal of haematology 2006;77(5):387-94.
2006: Marco Herling; George Z Rassidakis; Theodoros P Vassilakopoulos; L Jeffrey Medeiros; Andreas H Sarris
Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma.
Blood 2006;107(3):1240; author reply 1241.
2006: Deborah A Thomas; Andreas H Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien; Francis Giles; Guillermo Garcia-Manero; Maria A Rodriguez; Fernando Cabanillas; Andrew Lamb
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Cancer 2006;106(1):120-7.
2005: Jorge Romaguera; Luis Fayad; Maria A Rodriguez; Kristine Broglio; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth Katz; Harish K Gagneja; Barry Samuels; Terry L Smith; Fernando Cabanillas
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: Andre Goy; Anas Younes; Peter McLaughlin; Barbara Pro; Jorge Romaguera; Fredrick Hagemeister; Luis Fayad; Nam H Dang; Felipe Samaniego; Michael Wang; Kristine Broglio; Barry Samuels; Frederic Gilles; Andreas H Sarris; Susan Hart; Elizabeth Trehu; David P Schenkein; Fernando Cabanillas; Alma M Rodriguez
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2004: Carlo Visco; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; L Jeffrey Medeiros; P Notti; George Z Rassidakis; Prema P Peethambaram; Richard Wilder; Thomas E Witzig; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Marco Herling; George Z Rassidakis; Dan Jones; Annette Schmitt-Graeff; Andreas H Sarris; L Jeffrey Medeiros
Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria.
Human pathology 2004;35(4):455-9.
2004: Gregory M Chronowski; Richard B Wilder; Lawrence B Levy; E Neely Atkinson; Chul Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
American journal of clinical oncology 2004;27(1):73-80.
2003: Nam H Dang; Fredrick B Hagemeister; Madeleine Duvic; Jorge Romaguera; Anas Younes; Dan Jones; Barry Samuels; Luis Fayad; Barbara Pro; Felipe Samaniego; Andreas H Sarris; Andre Goy; Peter McLaughlin; Ann T Tong; Pamela L Walker; Lili Paz Tiongson; Terry L Smith; Yang O Huh; Chikao Morimoto; Maria A Rodriguez
Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Oncology reports 2003;10(5):1513-8.
2003: George Z Rassidakis; Andre Goy; L Jeffrey Medeiros; Yunfang Jiang; Athanasios Thomaides; Yvonne K Remache; Fernando Cabanillas; Andreas H Sarris; Frederic Gilles
Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2213-20.
2003: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: George Z Rassidakis; Dan Jones; Raymond Lai; Preetha Ramalingam; Andreas H Sarris; Timothy J McDonnell; L Jeffrey Medeiros
BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
The Journal of pathology 2003;200(2):240-8.
2003: George Z Rassidakis; Francois Claret; Raymond Lai; Qingxiu Zhang; Andreas H Sarris; Timothy J McDonnell; L Jeffrey Medeiros
Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1121-8.
2003: Jorge Romaguera; L Jeffrey Medeiros; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; Barbara Pro; Anas Younes; Peter McLaughlin; Andre Goy; Andreas H Sarris; Nam H Dang; Felipe Samaniego; H M Brown; Harish K Gagneja; Fernando Cabanillas
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer 2003;97(3):586-91.
2002: Gregory M Chronowski; Richard B Wilder; Susan L Tucker; Chul Ha; Andreas H Sarris; Fredrick B Hagemeister; Ibrahim Barista; Mark A Hess; Fernando Cabanillas; James D Cox
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Cancer 2002;95(12):2534-8.
2002: Apostolia-Maria Tsimberidou; Peter McLaughlin; Anas Younes; Maria A Rodriguez; Fredrick B Hagemeister; Andreas H Sarris; Jorge Romaguera; Mark Hess; Terry L Smith; Ying Yang; Ana Ayala; Alejandro Preti; Ming-Sheng Lee; Fernando Cabanillas
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 2002;100(13):4351-7.
2002: George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Timothy J McDonnell; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Apostolia-Maria Tsimberidou; Yunfang Jiang; Richard J Ford; Benjamin Lichtiger; L Jeffrey Medeiros; Peter McLaughlin; Fernando Cabanillas; Andreas H Sarris
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Leukemia & lymphoma 2002;43(8):1589-98.
2002: Andreas H Sarris; Alexandria Phan; Andre Goy; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; L Jeffrey Medeiros; Barry Samuels; Ofelia M Mesina; Archie Bleyer; Fernando Cabanillas
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):27-31.
2002: Carlo Visco; L Jeffrey Medeiros; Dan Jones; T Smith; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1290-9.
2002: Andreas H Sarris; Alexandria Phan; Madeleine Duvic; Jorge Romaguera; Peter McLaughlin; Ofelia M Mesina; K King; L Jeffrey Medeiros; George Z Rassidakis; Barry Samuels; Fernando Cabanillas
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2876-80.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Andreas H Sarris; Yunfang Jiang; Apostolia-Maria Tsimberidou; Athanasios Thomaides; George Z Rassidakis; Richard J Ford; L Jeffrey Medeiros; Fernando Cabanillas; Peter McLaughlin
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Seminars in oncology 2002;29(1 Suppl 2):48-55.
2002: George Z Rassidakis; L Jeffrey Medeiros; Timothy J McDonnell; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Dan Jones; Francisco Vega; Andreas H Sarris; L Jeffrey Medeiros
CD4-CD8-"Double-negative" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course.
The American journal of surgical pathology 2002;26(2):225-31.
2002: Yunfang Jiang; L Jeffrey Medeiros; Andreas H Sarris
Detection of t(2;5)(p23;q35) translocation by long-range PCR of genomic DNA.
Methods in molecular medicine 2002;68():97-105.
2001: Marco Herling; George Z Rassidakis; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; ALESSANDRO MASSIMO GIANNI; SW Morris; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Leukemia & lymphoma 2001;42(5):969-79.
2001: George Z Rassidakis; Andreas H Sarris; Marco Herling; Richard J Ford; Fernando Cabanillas; Timothy J McDonnell; L Jeffrey Medeiros
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
The American journal of pathology 2001;159(2):527-35.
2001: Bouthaina S Dabaja; Susan M O'Brien; Hagop M Kantarjian; Jorge E Cortes; Deborah A Thomas; Maher Albitar; E S Schlette; Stefan Faderl; Andreas H Sarris; Michael J Keating; Francis Giles
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
Leukemia & lymphoma 2001;42(3):329-37.
2001: Andreas H Sarris; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; Anas Younes; Ofelia M Mesina; Fernando Cabanillas; L Jeffrey Medeiros; Barry Samuels
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):53-6.
2001: Carlo Visco; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Clinical lymphoma 2001;2(1):40-6.
2001: Apostolia-Maria Tsimberidou; Andreas H Sarris; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Jorge Romaguera; Barbara Pro; Peter McLaughlin; N Dang; Fernando Cabanillas
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Leukemia & lymphoma 2001;41(5-6):535-44.
2001: M Crow; D D Taub; S Cooper; Hal E Broxmeyer; Andreas H Sarris
Human recombinant interferon-inducible protein-10: intact disulfide bridges are not required for inhibition of hematopoietic progenitors and chemotaxis of T lymphocytes and monocytes.
Journal of hematotherapy & stem cell research 2001;10(1):147-56.
2001: M K Crow; N Karasavvas; Andreas H Sarris
Protein aggregation mediated by cysteine oxidation during the stacking phase of discontinuous buffer SDS-PAGE.
BioTechniques 2001;30(2):311-6.
2001: Andreas H Sarris; Ira Braunschweig; L Jeffrey Medeiros; Madeleine Duvic; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; J Cox; Fernando Cabanillas
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):398-405.
2000: Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Andreas H Sarris; O Pate; Anas Younes; Ming-Sheng Lee; Nam H Dang; Jorge Romaguera; Alejandro Preti; N McAda; Fernando Cabanillas
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):37-41.
2000: Andreas H Sarris; A Psyrri; Fredrick Hagemeister; Jorge Romaguera; Peter McLaughlin; Maria A Rodriguez; CR Bachier; Anas Younes; Ofelia M Mesina; M Oholendt; L Jeffrey Medeiros; Barry Samuels; Laurel M Adams; Fernando Cabanillas
Infusional vinorelbine in relapsed or refractory lymphomas.
Leukemia & lymphoma 2000;39(3-4):291-9.
2000: Paolo Anderlini; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Sandra Acholonu; Agueda Cohen; Martin Körbling; J Manning; Jorge Romaguera; Andreas H Sarris; Fredrick Hagemeister; Peter McLaughlin; Fernando Cabanillas; Richard E Champlin
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Jorge Romaguera; Issa F Khouri; Hagop M Kantarjian; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Anas Younes; Jose Rodriguez; Fernando Cabanillas
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Leukemia & lymphoma 2000;39(1-2):77-85.
2000: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():137-40.
2000: Andreas H Sarris; Fredrick Hagemeister; Jorge Romaguera; Maria A Rodriguez; Peter McLaughlin; Apostolia-Maria Tsimberidou; L Jeffrey Medeiros; Barry Samuels; O Pate; M Oholendt; Andrew Lamb; C Burge; Fernando Cabanillas
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):69-72.
1999: Michele L Donato; Richard E Champlin; Koen van Besien; Martin Korbling; Fernando Cabanillas; Paolo Anderlini; J G Gajewski; Jo Lauppe; April Durett; Borje Andersson; Sergio Giralt; Issa Khouri; Fredrick Hagemeister; Jorge Romaguera; Andreas H Sarris; Peter McLaughlin; Anas Younes; Cindy Ippoliti; D A Blamble; Jeane Hester; Adrian Gee; Maria A Rodriguez
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Rajyalakshmi Luthra; Andreas H Sarris; Seema Hai; A V Paladugu; Jorge Romaguera; Fernando Cabanillas; L Jeffrey Medeiros
Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).
American journal of clinical pathology 1999;112(4):524-30.
1999: G Steinbach; R Ford; GA Glober; Dory A Sample; Fredrick B Hagemeister; Patrick M Lynch; P W McLaughlin; M A Rodriguez; Jorge Romaguera; Andreas H Sarris; Anas Younes; R Luthra; JT Manning; C M Johnson; Sandeep Lahoti; Y Shen; J E Lee; RJ Winn; Robert Genta; D Y Graham; Fernando Cabanillas
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Annals of internal medicine 1999;131(2):88-95.
1999: Jose Rodriguez; Maria A Rodriguez; Luis Fayad; Peter McLaughlin; F Swan; Andreas H Sarris; Jorge Romaguera; Borje Andersson; Fernando Cabanillas; Fredrick B Hagemeister
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Blood 1999;93(11):3632-6.
1999: A López-Guillermo; Fernando Cabanillas; Timothy J McDonnell; Peter McLaughlin; T Smith; WC Pugh; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; Ming-Sheng Lee
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
Blood 1999;93(9):3081-7.
1999: Andreas H Sarris; Kay-Oliver Kliche; P Pethambaram; Alejandro Preti; S Tucker; CM Jackow; O Messina; WC Pugh; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Herbert A Fritsche; T Witzig; Madeleine Duvic; Michael Andreeff; Fernando Cabanillas
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):433-40.
1999: Jorge Romaguera; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; J Rodriguez; A Preti; Anas Younes; Andreas H Sarris; Fernando Cabanillas
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Investigational new drugs 1999;17(2):187-92.
1998: Jorge Romaguera; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; CR Bachier; H Alejandro Preti; Andreas H Sarris; Donna Weber; Anas Younes; Fernando Cabanillas
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;32(1-2):97-106.
1998: Anas Younes; Jorge Romaguera; Ofelia M Mesina; Fredrick Hagemeister; Andreas H Sarris; Maria A Rodriguez; Peter McLaughlin; H Alejandro Preti; CR Bachier; Fernando Cabanillas
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
British journal of haematology 1998;103(3):678-83.
1998: Rajyalakshmi Luthra; JA McBride; Fernando Cabanillas; Andreas H Sarris
Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma.
The American journal of pathology 1998;153(1):63-8.
1998: Andreas H Sarris; Rajyalakshmi Luthra; Fernando Cabanillas; SW Morris; WC Pugh
Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Leukemia & lymphoma 1998;29(5-6):507-14.
1998: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
The clinical significance of molecular response in indolent follicular lymphomas.
Blood 1998;91(8):2955-60.
1998: Danai D Daliani; R A Ulmer; CM Jackow; WC Pugh; B Gansbacher; Fernando Cabanillas; Madeleine Duvic; Andreas H Sarris
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
Leukemia & lymphoma 1998;29(3-4):315-28.
1998: Koen van Besien; Chul Ha; S Murphy; Peter McLaughlin; A Rodriguez; K Amin; A Forman; Jorge Romaguera; Fredrick Hagemeister; Anas Younes; CR Bachier; Andreas H Sarris; K S Sobocinski; James D Cox; Fernando Cabanillas
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Rajyalakshmi Luthra; WC Pugh; M Waasdorp; W Morris; Fernando Cabanillas; P K Chan; Andreas H Sarris
Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Hematopathology and molecular hematology 1998;11(3-4):173-83.
1998: Jorge Romaguera; J Rodríguez Díaz-Pavon; L Carías; Fredrick B Hagemeister; Peter McLaughlin; M A Rodríguez; Andreas H Sarris; Anas Younes; Alejandro Preti; CR Bachier; E Llerena; Fernando Cabanillas
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Leukemia & lymphoma 1998;28(3-4):295-306.
1997: Anas Younes; Maria A Rodriguez; Peter McLaughlin; LB North; Andreas H Sarris; O Pate; Fredrick B Hagemeister; Jorge Romaguera; Alejandro Preti; CR Bachier; Fernando Cabanillas
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;26(1-2):77-82.
1997: Andreas H Sarris; V Papadimitrakopoulou; Meletios A Dimopoulos; T Smith; WC Pugh; Chul Ha; Peter McLaughlin; David L Callender; J Cox; Fernando Cabanillas
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Leukemia & lymphoma 1997;26(1-2):49-56.
1997: Meletios A Dimopoulos; Danai D Daliani; WC Pugh; David M Gershenson; Fernando Cabanillas; Andreas H Sarris
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy.
Gynecologic oncology 1997;64(3):446-50.
1997: Andreas H Sarris; Danai D Daliani; R Ulmer; M Crow; H E Broxmeyer; M Reiss; N Karasavvas; Andrew D Zelenetz; WC Pugh; Fernando Cabanillas; Albert Deisseroth; Madeleine Duvic
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):169-77.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; Fredrick Hagemeister; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; R Kurzrock; Alejandro Preti; CR Bachier; T Smith; Fernando Cabanillas
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
British journal of haematology 1997;96(2):328-32.
1997: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; A Deisseroth; SW Morris; WC Pugh
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():59-63.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; CR Bachier; Alejandro Preti; Fernando Cabanillas
Paclitaxel (Taxol) for the treatment of lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():129-31.
1996: Andreas H Sarris; Danai D Daliani; R Ulmer; M Crow; H E Broxmeyer; WC Pugh; M Reiss; Fernando Cabanillas; Albert Deisseroth; Madeleine Duvic
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.
Leukemia & lymphoma 1996;24(1-2):103-10.
1996: Anas Younes; Fernando Cabanillas; P W McLaughlin; F B Hagemeister; Charles Michael Farber; Andreas H Sarris; O Pate; J Myers; Carol S Portlock
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1083-5.
1996: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; Albert Deisseroth; S W Morris; WC Pugh
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Blood 1996;88(5):1771-9.
1996: Andreas H Sarris; Moshe Talpaz; Albert Deisseroth; Zeev Estrov
Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Leukemia 1996;10(5):757-65.
1996: Peter McLaughlin; F B Hagemeister; Jorge Romaguera; Andreas H Sarris; O Pate; Anas Younes; F Swan; Michael Keating; Fernando Cabanillas
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: Andreas H Sarris; J Cortes; Andrew Lamb; Sherry Pierce; T Smith; Michael Keating; Charles Koller; Steven M Kornblau; Susan O'Brien; Michael Andreeff
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Leukemia & lymphoma 1996;21(1-2):85-92.
1996: Anas Younes; Andreas H Sarris; U Consoli; A Rodriguez; Peter McLaughlin; Y Huh; S Starry; Fernando Cabanillas; Michael Andreeff
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
Blood 1996;87(5):1698-703.
1996: Anas Younes; JP Ayoub; F B Hagemeister; Peter McLaughlin; Andreas H Sarris; Maria A Rodriguez; F Swan; Jorge Romaguera; J Martin; Fernando Cabanillas
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):543-8.
1996: Andreas H Sarris; Anas Younes; Peter McLaughlin; D Moore; F Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; LB North; P Mansfield; D Callendar; O Mesina; Fernando Cabanillas
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):233-9.
1995: Andreas H Sarris; T Esgleyes-Ribot; M Crow; H E Broxmeyer; N Karasavvas; WC Pugh; D Grossman; Albert Deisseroth; Madeleine Duvic
Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?
Blood 1995;86(2):651-8.
1995: Andreas H Sarris; Meletios A Dimopoulos; WC Pugh; Fernando Cabanillas
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
The Journal of urology 1995;153(6):1852-4.
1995: N Touroutoglou; Meletios A Dimopoulos; Anas Younes; M Hess; WC Pugh; J Cox; Fernando Cabanillas; Andreas H Sarris
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1361-7.
1995: Andreas H Sarris; Alejandro Majlis; Meletios A Dimopoulos; Anas Younes; F Swann; Maria A Rodriguez; Peter McLaughlin; Fernando Cabanillas
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.
1995: Anas Younes; Andreas H Sarris; A Melnyk; Jorge Romaguera; Peter McLaughlin; F Swan; Maria A Rodriguez; F Hagemeister; D Moore; LB North
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):583-7.
1995: D F Moore; F Swan; J Yau; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Jorge Romaguera; Anas Younes; F B Hagemeister; Fernando Cabanillas
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(5):300-3.
1994: Anas Younes; Johannes Drach; R Katz; David Jendiroba; M H Sabourian; Andreas H Sarris; F Swan; D Hill; Fernando Cabanillas; R Ford
Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):265-8.
1994: Jorge Romaguera; Maria A Rodriguez; F B Hagemeister; Peter McLaughlin; F Swan; D F Moore; Andreas H Sarris; Anas Younes; D Hill; Fernando Cabanillas
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Investigational new drugs 1994;12(3):217-22.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; Jorge Romaguera; Maria A Rodriguez; M S Lee; O Pate; Andreas H Sarris; Anas Younes
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():73-7.
1993: Andreas H Sarris; H E Broxmeyer; U Wirthmueller; N Karasavvas; S Cooper; L Lu; J Krueger; Jeffrey V Ravetch
Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors.
The Journal of experimental medicine 1993;178(3):1127-32.
1992: Andreas H Sarris; Sanford J. Kempin; Ellin Berman; J Michaeli; C Little; M Andreeff; T Gee; David J Straus; B Gansbacher; Daniel A Filippa
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia.
Blood 1992;79(5):1305-10.
1989: S C Gulati; B Shank; Andreas H Sarris; Ellin Berman; T Gee; I Cunningham; N Flomenberg; Richard J O'Reilly; Bayard Clarkson
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Bone marrow transplantation 1989;4 Suppl 1():116-8.